Wen et al. (2018) showed that BCAA transaminase 1 (BCAT1), a key enzyme in BCAA catabolism, is overexpressed in NPC and promotes cell proliferation, making it a promising molecular target for NPC treatment 25. This evidence concerns the gene BCAT1 and nasopharyngeal carcinoma.